Collagen Solutions

Collagen Solutions Plc (AIM:COS) is a global provider of medical grade collagen formulations and components for use in regenerative medicine, medical devices and in-vitro diagnostics.

Collagen Solutions Plc was established and admitted to the London Stock Exchange on the 2nd January 2014 when Collbio Limited acquired the assets of Collagen Solutions LLC and went through a simultaneous reverse takeover into Healthcare Investment Opportunities plc, which became Collagen Solutions Plc. On 10th December 2014, by way of reverse takeover, Collagen Solutions Plc, acquired Southern Lights Biomaterials based in New Zealand, being a logical strategic extension and complementary in nature to the Group’s existing business model.

Collagen Solutions provides customers with medical grade collagen products and development services to create collagen components from concept to clinical trial stage, including technology transfer and contract manufacturing.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.